HK1166017A1 - 引起神經突生長的組合物和方法 - Google Patents

引起神經突生長的組合物和方法

Info

Publication number
HK1166017A1
HK1166017A1 HK12106832.5A HK12106832A HK1166017A1 HK 1166017 A1 HK1166017 A1 HK 1166017A1 HK 12106832 A HK12106832 A HK 12106832A HK 1166017 A1 HK1166017 A1 HK 1166017A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
neurite outgrowth
causing
causing neurite
Prior art date
Application number
HK12106832.5A
Other languages
English (en)
Inventor
武井義則
Original Assignee
醫藥研究委員會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 醫藥研究委員會 filed Critical 醫藥研究委員會
Publication of HK1166017A1 publication Critical patent/HK1166017A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
HK12106832.5A 2009-03-06 2012-07-11 引起神經突生長的組合物和方法 HK1166017A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0903913.2A GB0903913D0 (en) 2009-03-06 2009-03-06 Compositions and methods
PCT/GB2010/000391 WO2010100428A2 (en) 2009-03-06 2010-03-05 Compositions and methods

Publications (1)

Publication Number Publication Date
HK1166017A1 true HK1166017A1 (zh) 2012-10-19

Family

ID=40600640

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106832.5A HK1166017A1 (zh) 2009-03-06 2012-07-11 引起神經突生長的組合物和方法

Country Status (11)

Country Link
US (1) US9089565B2 (zh)
EP (1) EP2403515B1 (zh)
JP (1) JP5670921B2 (zh)
CN (1) CN102341117B (zh)
AU (1) AU2010219463A1 (zh)
CA (1) CA2750911A1 (zh)
DK (1) DK2403515T3 (zh)
ES (1) ES2493619T3 (zh)
GB (1) GB0903913D0 (zh)
HK (1) HK1166017A1 (zh)
WO (1) WO2010100428A2 (zh)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3214099A (en) 1998-04-03 1999-10-25 Curagen Corporation Lyst protein complexes and lyst interacting proteins
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
EP1537138A2 (en) * 2001-07-17 2005-06-08 Incyte Genomics, Inc. Receptors and membrane-associated proteins
JP2003093056A (ja) 2001-09-26 2003-04-02 Japan Science & Technology Corp ｐ５３のＳｅｒ４６をリン酸化する酵素
WO2005000114A2 (en) 2003-06-03 2005-01-06 Bayer Healthcare Llc Portable medical diagnostic apparatus
GB0314943D0 (en) * 2003-06-25 2003-07-30 Proteome Sciences Plc Screening methods
CN1849132A (zh) * 2003-09-10 2006-10-18 伦敦大学国王学院 调节神经元生长的化合物以及它们的用途
JP2007514748A (ja) * 2003-12-16 2007-06-07 チルドレンズ メディカル センター コーポレーション 神経障害を処置するための方法
US20050214288A1 (en) * 2004-03-26 2005-09-29 Human Genome Sciences, Inc. Antibodies against Nogo receptor
US7846438B2 (en) 2004-08-03 2010-12-07 Biogen Idec Ma Inc. Methods of promoting neurite outgrowth with soluble TAJ polypeptides
US7414637B2 (en) * 2004-09-10 2008-08-19 Telmap Ltd. Placement of map labels
WO2008116032A1 (en) 2007-03-21 2008-09-25 Effat Emamian Compositions and methods for inhibiting tumor cell growth

Also Published As

Publication number Publication date
US20110318326A1 (en) 2011-12-29
WO2010100428A2 (en) 2010-09-10
AU2010219463A1 (en) 2011-09-22
CN102341117A (zh) 2012-02-01
DK2403515T3 (da) 2014-08-11
GB0903913D0 (en) 2009-04-22
JP2012519676A (ja) 2012-08-30
US9089565B2 (en) 2015-07-28
CA2750911A1 (en) 2010-09-10
EP2403515B1 (en) 2014-05-21
CN102341117B (zh) 2015-01-21
WO2010100428A3 (en) 2010-10-21
JP5670921B2 (ja) 2015-02-18
ES2493619T3 (es) 2014-09-12
EP2403515A2 (en) 2012-01-11

Similar Documents

Publication Publication Date Title
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
IL216550A (en) Polymeric Compounds with an Immunogenic modulator, Preparations Containing Them, Methods of Preparation and Use
GB0908129D0 (en) Composition
GB0815872D0 (en) Novel method and compositions
HK1215025A1 (zh) 純化的吡咯並喹啉基-吡咯烷- -二酮組合物和用於製備且使用其的方法
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
ZA201107838B (en) Composition
GB0909362D0 (en) Composition
GB0912468D0 (en) Composition and method
EP2294199A4 (en) COMPOSITIONS AND METHODS FOR ENHANCING PLANTS
GB0908642D0 (en) Composition
GB0901966D0 (en) Composition
EP2490536A4 (en) COMPOSITION AND METHOD
EP2394634A4 (en) HESPERIDO-CONTAINING COMPOSITION
EP2294198A4 (en) METHODS AND COMPOSITIONS FOR ENHANCING PLANTS
GB0906779D0 (en) Composition
GB0904941D0 (en) Composition
EP2444061A4 (en) COMPOSITION CONTAINING APIGENIN
GB0904942D0 (en) Composition
GB0901494D0 (en) Compositions and Methods
GB0906548D0 (en) Composition
GB0903688D0 (en) Composition
IL217764A0 (en) Methods and compositions for treating leukemia
GB0901667D0 (en) Composition and method
GB0902959D0 (en) Composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180305